Alpha-1 antitrypsin in childhood asthma. 1977

R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai

Alpha-1 antitrypsin (AAT) phenotypes and serum levels were studied in two childhood perennial asthmatic populations. The first was an ambulatory, mostly mild nonsteroid-dependent group living in Rochester, N.Y. The second was a more severe mostly steroid-dependent group residing at an asthma residential treatment center in Denver, Colo. The prevalences of alpha-1 antitrypsin protease inhibitor (Pi) tyes were the same for bothe groups and similar to prevalences in a random population. Alpha-1 antitrypsin serum levels were significantly elevated for the mild nonsteroid-dependent group when compared to the more severe steroid-dependent group. The steroid-dependent group had serum levels similar to a group of nonasthmatic control children. These findings indicate that there is not a strong association of alpha-1 antitrypsin Pi variants such as Pi MZ or Pi MS with more severe asthma. Elevated serum levels in the milk perennial asthmatic group may be the result of chronic inflammatory processes. Normal levels in the sterioid-dependent group may be the result of corticosteroid control of inflammation associated with asthma.

UI MeSH Term Description Entries
D008297 Male Males
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000515 alpha 1-Antitrypsin Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
December 1985, Revue francaise de transfusion et immuno-hematologie,
R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
November 1980, Current problems in pediatrics,
R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
January 1979, Kinderarztliche Praxis,
R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
April 1974, The American review of respiratory disease,
R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
July 1972, The Proceedings of the Institute of Medicine of Chicago,
R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
April 1986, Indian pediatrics,
R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
January 2011, Fetal and pediatric pathology,
R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
July 1978, Pediatrics,
R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
January 1973, British journal of diseases of the chest,
R H Schwartz, and J D Van Ess, and D E Johnstone, and E M Dreyfuss, and M A Abrishami, and H Chai
June 1994, Chest,
Copied contents to your clipboard!